Cargando…
A pharmacological approach in newly established retinal vein occlusion model
The mechanism underlying the effects of anti-vascular endothelial growth factor (VEGF) antibody in retinal vein occlusion (RVO) treatment is poorly understood, partly due to the lack of RVO animal models that mimic clinical pathology. The aims of this study were to establish a suitable RVO model, cl...
Autores principales: | Fuma, Shinichiro, Nishinaka, Anri, Inoue, Yuki, Tsuruma, Kazuhiro, Shimazawa, Masamitsu, Kondo, Mineo, Hara, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333144/ https://www.ncbi.nlm.nih.gov/pubmed/28252108 http://dx.doi.org/10.1038/srep43509 |
Ejemplares similares
-
Oral and ocular administration of crocetin prevents retinal edema in a murine retinal vein occlusion model
por: Nitta, Koki, et al.
Publicado: (2019) -
Photobiomodulation with 670 nm light increased phagocytosis in human retinal pigment epithelial cells
por: Fuma, Shinichiro, et al.
Publicado: (2015) -
Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model
por: Nakamura, Shinsuke, et al.
Publicado: (2022) -
The Changes in Blood Flow Seen in the Eye after Foot Acupuncture Treatment in Mice
por: Nishinaka, Anri, et al.
Publicado: (2020) -
Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells
por: Izuta, Hiroshi, et al.
Publicado: (2009)